Q & A

Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.

ImmuPharma PLC Q&A with Vadim Alexandre Head of Research at Northland Capital Partners (LON:IMM)

ImmuPharma PLC (LON:IMM) is the topic of conversation when Northland Capital Partners Head of Research Vadim Alexandre caught up with DirectorsTalk for an exclusive interview   Q1: Now Vadim, you..

WideCells Group PLC Q&A with CEO João Andrade & CFO David Bridgland (LON:WDC)

WideCells Group PLC (LON:WDC) Chief Executive Officer João Andrade and Chief Financial Officer David Bridgland caught up with DirectorsTalk for an exclusive interview to discuss the agreement with Hemocord, the..

Versarien PLC Q&A with CEO Neill Ricketts: Final Results for Year-Ended 31 March 2017 (LON:VRS)

Versarien PLC (LON:VRS) Chief Executive Officer Neill Ricketts caught up with DirectorsTalk for an exclusive interview to discuss their final results for the year ended 31st March 2017   Q1:..

Transense Technologies plc Q&A with CEO Graham Storey: Further Contract Win with Glencore Plc (LON:TRT)

Transense Technologies Plc (LON:TRT) Chief Executive Officer Graham Storey caught up with DirectorsTalk for an exclusive interview to discuss their third contract with Glencore Plc, the benefits of using a..

Widecells Group Plc Q&A with CEO João Andrade – Launch of CellPlan (LON:WDC)

Widecells Group Plc (LON:WDC) Chief Executive Officer João Andrade caught up with DirectorsTalk for an exclusive interview to discuss the launch of CellPlan, the UK’s first insurance product for stem..

Defenx PLC Q&A with CFO Philipp Prince: Software Distribution Contract and Trading Update (LON:DFX)

Defenx PLC (LON:DFX) Chief Financial Officer Philipp Prince caught up with DirectorsTalk for an exclusive interview to discuss their software distribution contract with BV-Tech, de-risking the business, the causes of..

Goldplat plc Q&A with CEO Gerard Kisbey-Green: Latest Operational Update (LON:GDP)

Goldplat plc (LON:GDP) Chief Executive Officer Gerard Kisbey-Green caught up with DirectorsTalk for an exclusive interview to discuss their latest operational update   Q1: You have noted at a new..

Gresham House plc Q&A with CEO Tony Dalwood (LON:GHE)

Gresham House plc (LON:GHE) Chief Executive Officer Tony Dalwood caught up with DirectorsTalk for an exclusive interview to discuss the rationale for the business, investment strategies and asset classes, how..

Q&A: Advanced Oncotherapy PLC Steve Myers

Advanced Oncotherapy PLC (LON:AVO) subsidiary ADAM S.A. Executive Chairman professor Steve Myers talks to DirectorsTalk about the LIGHT system, it’s likely impact, the design, the progress being made and its..

Elegant Hotels Group PLC Q&A with CEO Sunil Chatrani: Half-Year Report (LON:EHG)

Elegant Hotels Group PLC (LON:EHG) Chief Executive Officer Sunil Chatrani caught up with DirectorsTalk for an exclusive interview to discuss their half year report   Q1: Now, in your comments..

Widecells Group Plc Q&A with CEO João Andrade & WideAcademy VP Alan Greenberg (LON:WDC)

Widecells Group Plc (LON:WDC) Chief Executive Officer João Andrade and Vice President of Wide Academy Alan Greenberg caught up with DirectorsTalk for an exclusive interview to discuss the WideAcademy strategy,..

Evgen Pharma PLC Q&A with Chief Executive Officer Dr Stephen Franklin (LON:EVG)

Evgen Pharma PLC (LON:EVG) Chief Executive Officer Dr Stephen Franklin caught up with DirectorsTalk for an exclusive interview to discuss their final results for year-ended 31st March 2017   Q1:..

Lionsgold Ltd Q&A with CEO Cameron Parry: Indian Gold Portfolio Valuation and Project Update (LON:LION)

Lionsgold Ltd (LON:LION) Chief Executive Officer Cameron Parry caught up with DirectorsTalk for an exclusive interview to discuss its Indian Gold Portfolio Valuation and Project Update   Q1: Why is..

ImmuPharma PLC Q&A with Chairman Tim McCarthy: Phase III Lupuzor Study Update

ImmuPharma PLC (LON:IMM) Chairman Tim McCarthy caught up with DirectorsTalk for an exclusive interview to discuss the latest update on their Phase III Lupuzor study   Q1: Now Tim, ImmuPharma..

Veltyco Group PLC Q&A: Final Results for Year Ended 31 December 2016 (LON:VLTY)

Veltyco Group PLC (LON:VLTY) Chairman David Mathewson caught up with DirectorsTalk for an exclusive interview to discuss their final results for year ended 31 December 2016   Q1: David, Veltyco..

Hardide Plc Q&A with CEO Philip Kirkham: Interim Results (LON:HDD)

Hardide Plc (LON:HDD) Chief Executive Officer Philip Kirkham caught up with DirectorsTalk for an exclusive interview to discuss their interim results   Q1: Now Phil, Hardide’s half year results just..

Accrol Group Holdings PLC Q&A with Mike Allen Head of Research at Zeus Capital (LON:ACRL)

Accrol Group Holdings PLC (LON:ACRL) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview   Q1: Now, Accrol..

Ceres Power Holdings plc Q&A with Zeus Capital’s Dr Tom McColm (LON:CWR)

Zeus Capital Research Director Dr Tom McColm caught up with DirectorsTalk for an exclusive interview to discuss Ceres Power Holdings plc (LON:CWR)   Q1: Tom, can you talk us through..

Vertu Motors Plc Q&A with Mike Allen Head of Research at Zeus Capital (LON:VTU)

Zeus Capital Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview to discuss Vertu Motors Plc (LON:VTU)   Q1: Mike, can you shares your thoughts for..

Redstoneconnect PLC Q&A with Whitman Howard Analyst Andy Smith (LON:REDS)

Whitman Howard Analyst Andy Smith caught up with DirectorsTalk for an exclusive interview to discuss Redstoneconnect PLC (LON:REDS)   Q1: Now Andy, Redstoneconnect announced the acquisition of Anders + Kern,..

Search

Funds

Q & A

Search

Funds

Q & A

FTSE 100

Funds